NVCT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Nuvectis Pharma Inc (NVCT).


$104.53M Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

NVCT Market Cap. (MRY)


NVCT Shares Outstanding (MRY)


NVCT Assets (MRY)


Total Assets

$18.61M

Total Liabilities

$8.89M

Total Investments

$0

NVCT Income (MRY)


Revenue

$0

Net Income

-$19.00M

Operating Expense

$19.85M

NVCT Cash Flow (MRY)


CF Operations

-$12.25M

CF Investing

$0

CF Financing

$11.65M

NVCT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

0%

0%

-

2020

$0

-

-

0%

-

NVCT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$18,607,000 (-3.01%)

$19,185,000 (-5.98%)

$20,405,000 (206.52%)

$6,657,000 (0%)

Assets Current

$18,607,000 (-3.01%)

$19,185,000 (-5.98%)

$20,405,000 (249.82%)

$5,833,000 (0%)

Assets Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$824,000 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$9,713,000 (-20.39%)

$12,201,000 (-14.19%)

$14,219,000 (229.17%)

-$11,008,000 (-109980.00%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$18,533,000 (-3.10%)

$19,126,000 (-4.34%)

$19,993,000 (248.19%)

$5,742,000 (0%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,498,000 (-9.85%)

$2,771,000 (-4.78%)

$2,910,000 (175.05%)

$1,058,000 (10480.00%)

Accumulated Retained Earnings (Deficit)

-$73,245,000 (-35.03%)

-$54,245,000 (-69.60%)

-$31,985,000 (-147.95%)

-$12,900,000 (-128900.00%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$8,894,000 (27.35%)

$6,984,000 (12.90%)

$6,186,000 (155.73%)

$2,419,000 (24090.00%)

Liabilities Current

$8,894,000 (27.35%)

$6,984,000 (12.90%)

$6,186,000 (155.73%)

$2,419,000 (24090.00%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

NVCT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$6,929,000 (-7.82%)

$7,517,000 (25.14%)

$6,007,000 (79.37%)

$3,349,000 (33390.00%)

Research & Development Expense

$12,918,000 (-16.01%)

$15,380,000 (16.28%)

$13,227,000 (38.58%)

$9,545,000 (0%)

Operating Expenses

$19,847,000 (-13.32%)

$22,897,000 (19.04%)

$19,234,000 (49.17%)

$12,894,000 (128840.00%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Weighted Average Shares

$17,113,169 (10.01%)

$15,556,655 (22.90%)

$12,657,651 (196.55%)

$4,268,285 (4168.28%)

Weighted Average Shares Diluted

$17,113,169 (10.01%)

$15,556,655 (22.90%)

$12,657,651 (196.55%)

$4,268,285 (4168.28%)

Earning Before Interest & Taxes (EBIT)

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$19,847,000 (13.32%)

-$22,897,000 (-19.04%)

-$19,234,000 (-49.17%)

-$12,894,000 (-128840.00%)

NVCT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$11,654,000 (-22.75%)

$15,087,000 (-45.75%)

$27,810,000 (82.41%)

$15,246,000 (0%)

Net Cash Flow from Operations

-$12,247,000 (23.24%)

-$15,954,000 (-17.66%)

-$13,559,000 (-42.67%)

-$9,504,000 (0%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$593,000 (31.60%)

-$867,000 (-106.08%)

$14,251,000 (148.19%)

$5,742,000 (0%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$11,654,000 (127.84%)

$5,115,000 (-83.95%)

$31,879,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

NVCT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-160.80% (-11.05%)

-144.80% (-15.01%)

-125.90% (-153.80%)

234.00%

Return on Average Assets (ROAA)

-102.80% (4.64%)

-107.80% (-8.89%)

-99.00% (74.44%)

-387.30%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

292.00% (-35.20%)

450.60% (-21.81%)

576.30% (-66.16%)

1702.80%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-4.87 (16.43%)

-5.83 (-17.41%)

-4.97

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

10.76 (-9.14%)

11.84 (53.36%)

7.72

-

Debt to Equity Ratio (D/E)

0.92 (60.14%)

0.57 (31.49%)

0.43 (297.73%)

-0.22 (78.00%)

Earnings Per Share (EPS)

-1.11 (22.38%)

-1.43 (5.30%)

-1.51 (50.00%)

-3.02 (-2920.00%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.72 (30.21%)

-1.03 (4.20%)

-1.07 (51.91%)

-2.23 (0%)

Book Value Per Share (BVPS)

0.57 (-27.55%)

0.78 (-30.19%)

1.12 (143.54%)

-2.58 (-2479.00%)

Tangible Assets Book Value Per Share (TABVPS)

1.09 (-11.84%)

1.23 (-23.51%)

1.61 (3.33%)

1.56 (0%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (16.67%)

-6 (-20.00%)

-5

-

Enterprise Value Over EBITDA (EV/EBITDA)

-4.6 (16.42%)

-5.5 (-21.81%)

-4.52

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

2.09 (-23.84%)

2.75 (-16.73%)

3.3 (36.83%)

2.41 (0%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$12,247,000 (23.24%)

-$15,954,000 (-17.66%)

-$13,559,000 (-42.67%)

-$9,504,000 (0%)

Enterprise Value (EV)

$87,357,464 (-28.66%)

$122,444,794 (42.08%)

$86,178,622

-

Earnings Before Tax (EBT)

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$19,000,000 (14.65%)

-$22,260,000 (-16.64%)

-$19,085,000 (-48.06%)

-$12,890,000 (-128800.00%)

Invested Capital

-$8,820,000 (-27.36%)

-$6,925,000 (-19.93%)

-$5,774,000 (-283.91%)

-$1,504,000 (-14940.00%)

Working Capital

$9,713,000 (-20.39%)

$12,201,000 (-14.19%)

$14,219,000 (316.49%)

$3,414,000 (34240.00%)

Tangible Asset Value

$18,607,000 (-3.01%)

$19,185,000 (-5.98%)

$20,405,000 (206.52%)

$6,657,000 (0%)

Market Capitalization

$104,526,464 (-27.67%)

$144,503,794 (31.58%)

$109,818,622

-

Average Equity

$11,813,500 (-23.16%)

$15,373,250 (1.39%)

$15,163,000 (375.24%)

-$5,509,000

Average Assets

$18,481,500 (-10.50%)

$20,649,000 (7.09%)

$19,281,750 (479.29%)

$3,328,500

Invested Capital Average

-$6,507,000 (-31.72%)

-$4,940,000 (-49.18%)

-$3,311,500 (-337.45%)

-$757,000

Shares

19,320,973 (11.51%)

17,326,594 (18.33%)

14,642,483 (26.22%)

11,601,127 (0.00%)